Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Clinical Journal of the American Society of Nephrology : CJASN|September 7, 2013
Treatment of idiopathic FSGS with adrenocorticotropic hormone gelJonathan Hogan, Andrew S Bomback, Kshama Mehta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2021
Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case SeriesSyeda B Ahmad, Dominick Santoriello, Pietro Canetta, et al.
Kidney International Reports|October 11, 2022
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G TrialAndrew S Bomback, David Kavanagh, Marina Vivarelli, et al.
Kidney International Reports|February 5, 2024
Iptacopan in Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 StudyMarina Vivarelli, Andrew S Bomback, Matthias Meier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 2011
Renal-limited 'lupus-like' nephritisAna Huerta, Andrew S Bomback, Vassilis Liakopoulos, et al.
Kidney International|February 5, 2019
The spectrum of kidney biopsy findings in patients with morbid obesityHae-Yoon Grace Choung, Andrew S Bomback, M Barry Stokes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 21, 2012
Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participantsGeorges Saab, Shu-Cheng Chen, Suying Li, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 13, 2018
Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case SeriesRupali S Avasare, Pietro A Canetta, Andrew S Bomback, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 23, 2013
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritisLaurence Beck, Andrew S Bomback, Michael J Choi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 23, 2010
Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP)Andrew S Bomback, Abhijit V Kshirsagar, Adam T Whaley-Connell, et al.
Pageof 17